Vani Santosh
Overview
Explore the profile of Vani Santosh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
1909
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarkar C, Mahadevan A, Chacko G, Rao S, Suri V, Uppin M, et al.
Pathology
. 2025 Jan;
57(2):253-266.
PMID: 39828477
Neuropathology has been in existence as a speciality in India since the 1950s. Its practice has kept pace with the developments in the field, paralleling advancements in neurosurgery and neurosciences,...
2.
Sarkar C, Rao S, Santosh V, Al-Hussaini M, Park S, Tihan T, et al.
Brain Pathol
. 2025 Jan;
e13329.
PMID: 39822111
The shift toward a histo-molecular approach in World Health Organization classification of central nervous system tumors (WHO CNS5) emphasizes the critical role of molecular testing, such as next-generation sequencing (NGS)...
3.
Chaturvedi A, Sadashiva N, Kalahasti S, Konar S, Krishna U, Ar P, et al.
Childs Nerv Syst
. 2024 Dec;
41(1):71.
PMID: 39730925
Introduction: Diffuse intrinsic pontine glioma (DIPG) in children comprises 80% of brainstem gliomas. In 2021, 5th edition of WHO CNS tumor classification defined H3K27M altered diffuse midline gliomas (DMGs) which...
4.
Jana S, Mondal M, Mahale S, Gupta B, Prasasvi K, Kandasami L, et al.
Elife
. 2024 Sep;
12.
PMID: 39302097
In tumors with WT p53, alternate mechanisms of p53 inactivation are reported. Here, we have identified a long noncoding RNA, (53 nactivating RIM28 ssociated NA), as an inhibitor of p53....
5.
Kundu P, Jain R, Kanuri N, Arimappamagan A, Santosh V, Kondaiah P
Cancer Genomics Proteomics
. 2024 Aug;
21(5):485-501.
PMID: 39191501
Background/aim: Glioblastomas (GBM) are infiltrative malignant brain tumors which mostly recur within a year's time following surgical resection and chemo-radiation therapy. Studies on glioblastoma cells following radio-chemotherapy, have been demonstrated...
6.
Rao S, Goyal A, Johnson A, Sadashiva N, Kulanthaivelu K, Vazhayil V, et al.
Brain Tumor Pathol
. 2024 Aug;
41(3-4):109-116.
PMID: 39154303
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently recognised tumor type with indolent behaviour with characteristic imaging and histomolecular features. We describe the clinical, imaging, histo-molecular features...
7.
Chaturvedi A, Sadashiva N, Shukla D, Konar S, Krishna U, Beniwal M, et al.
Clin Neurol Neurosurg
. 2024 Jul;
244:108449.
PMID: 39053322
Introduction: Diffuse midline glioma (DMG) is a relatively new entity which was introduced in the fourth edition of the WHO classification of CNS tumours in 2016 and later underwent revision...
8.
Mangalore S, Pradeep G, Murthy V, Bairwa P, Kumar P, Saini J, et al.
Indian J Nucl Med
. 2024 Jul;
39(2):87-97.
PMID: 38989312
Background And Purpose: Follow-up imaging of gliomas is crucial to look for residual or recurrence and to differentiate them from nontumoral tissue. Positron emission tomography (PET)-magnetic resonance imaging (MRI) is...
9.
Chaturvedi A, Sadashiva N, Kalahasti S, Konar S, Krishna U, Ar P, et al.
World Neurosurg
. 2024 May;
187:e870-e882.
PMID: 38734176
Background: Diffuse intrinsic pontine gliomas are aggressive tumors that carry a poor prognosis with a 2-year survival rate of <10%. The imaging appearance is often pathognomonic, and surgical biopsy is...
10.
Nadeem M, Goyal-Honavar A, Sravya P, Beniwal M, Santosh V, Dwarakanath S
World Neurosurg
. 2024 Apr;
187:e331-e339.
PMID: 38649022
Background: Meningiomas are the most frequent primary intracranial tumor. While histological grade and grade of excision are established predictors of recurrence, the predictive ability of other clinical features, such as...